Endocr Pract (2016) 22 Suppl 3:1203
Finley says her physician told her a prior authorization was on file, but when she tried to refill her prescription, the pharmacist told her that Zepbound was denied
As a result, Medicaid coverage of GLP-1 drugs for obesity treatment is optional for states, while coverage for other indications (diabetes, cardiovascular disease, and sleep apnea) is required
Published in 1993, this testing was overseen by Michael Nauck, a physician at the University of Gttingen in collaboration with Creutzfeldt, Holst and other colleagues
Whats next
Quitting a medication cold turkey may lead to withdrawal symptoms, so its best not to make any changes to your dose until you talk to your healthcare provider